Journal
EXPERT REVIEW OF NEUROTHERAPEUTICS
Volume 11, Issue 11, Pages 1609-1617Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERN.11.152
Keywords
advanced glycation end products; antidiabetic medications; cognition; dementia; diabetes; hypoglycemia; insulin resistance; mild cognitive impairment; neuropathology; vascular
Categories
Funding
- NIA [R01 AG034087]
- Irma T. Hirschl Award
Ask authors/readers for more resources
Diabetes and prediabetic states have consistently been shown to be risk factors for cognitive decline, mild cognitive impairment and dementia. The importance of these findings is that diabetes and diabetes-related factors are modifiable, potentially permitting interventions aimed at postponing or preventing dementia. However, diabetes control cannot yet be implemented universally in diabetic subjects as a strategy for dementia prevention since the mechanisms by which diabetes impairs brain function and cognition are not fully understood. It is not clear which of the diabetes-related factors is crucial to this relationship. In addition, strict diabetic control has been demonstrated to carry risk for certain diabetic populations. The aim of the current article is to discuss current understanding of the relationships of diabetes and some of its characteristics with dementia, and suggest future questions to be answered.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available